Seminar 1 *
New Insight in the Management of Lipid Disorders
Leonard S. Lilly, MD
More than one-third of adults in the United States are hypercholesterolemic and this common risk factor contributes greatly to cardiovascular morbidity and mortality. The risks of dyslipidemia are additive to those of other disorders such as diabetes, hypertension, smoking and the metabolic syndrome. This lecture will consider appropriate identification of patients who warrant antilipidemic therapy and the goals of lipid management in the context of important recent clinical studies and guidelines.
Seminar 2 *
Update on Schizophrenia Treatment
J. Raul Condemarin, MD
Schizophrenia is a severe psychiatric disorder with a worldwide prevalence of about 1%—1.5 million people in the USA. The mechanisms that underlie schizophrenia are far from clear but the early diagnosis and treatment of schizophrenia offers an advantage in the long term management of first episode schizophrenia. Obesity, diabetes, and metabolic syndrome, which are very prevalent in schizophrenic patients, will be discussed.
Seminar 3
Managing Challenging Wounds
Virginia Capasso, PhD, ANP-BC
The session will include an overview of the physiology of acute wound healing and the pathophysiology of chronic wounds, the characteristics of high frequency wounds, and the state of the science of wound management.
Seminar 4
Child Internet Safety
Ann W. Burgess, DNSc, APRN, BC
The internet provides predators with anonymous access to children. This session will present results of a study identifying children at risk for exploitation, strategies used by predators, effectiveness of filters, and nursing’s role in educating parents.
Seminar 5 *
Long Acting Reversible Contraception: Selection and Starting
Loretta Borgatta, MD, MPH
There has been increased use of long-acting contraceptives as the selection has expanded. Labeling and recommendations for IUD use have changed including acceptable times for insertion. Evidence for adverse effects on the bone from depomedroxyprogesterone will be reviewed and Implanon will be re-visited. Patterns of satisfaction with long-term use will be discussed.
* Eligible for pharmacology contact hours